CEPI: Achieving an unprecedented acceleration of vaccine development and global manufacturing capacity to prevent COVID-19.

May 27, 2020, 12:37 PM by Melodi Moore
CEPI announces a funding opportunity for the rapid development of vaccines against COVID-19.  This document describes the scope, requirements and processes for submission. 

The objective of this Call for Proposals is to support the rapid development of vaccines with a goal of achieving licensure/emergency authorization in 12-18 months or less and to ensure the availability of sufficient doses for wide-spread global deployment as soon as possible in 2021. This call is being issued in conjunction with the establishment of the Access to COVID-19 Tools (ACT) Accelerator (https://www.who.int/who-documents-detail/access-to-covid-19-tools-(act)-accelerator), a public-private partnership committed to speeding the development of and global access to diagnostics, therapeutics, and vaccines.

Deadline:  June 30, 2020